(Q30318977)

17 June 2017

1 reference

title

SR 57746A/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases (English)

1 reference

17 June 2017

3

Thomas Seufferlein

0 references

author name string

Marc Porzner

series ordinal

1

1 reference

17 June 2017

Tobias Müller

series ordinal

2

1 reference

17 June 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Expert Opinion on Investigational Drugs

17 June 2017

published in

1 reference

17 June 2017

volume

18

1 reference

17 June 2017

issue

11

1 reference

17 June 2017

page(s)

1765-1772

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

17 June 2017

1 reference

Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Ethnic variation in the incidence of ALS: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

An overview of chemotherapy-induced peripheral sensory neuropathy, focusing on oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Therapy of chemotherapy-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Trk receptors: roles in neuronal signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Biochemical and electrophysiological properties of SR 57746A, a new, potent 5-HT1A receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Potential antidepressant properties of SR 57746A, a novel compound with selectivity and high affinity for 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Reduced serotonin-1A receptor binding in social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Effect of the nonpeptide neurotrophic compound SR 57746A on the phenotypic survival of purified mouse motoneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

The non-peptide neuroprotective agents SR 57746A interacts with neurotrophin 3 to induce differentiation in the PC12 cell-line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

The ins and outs of lysophosphatidic acid signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Lysophosphatidic acid as a novel cell survival/apoptotic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Inhibition of lysophosphatidic acid-induced neurite retraction and cell rounding by SR 57746A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Effects of paliroden (SR57667B) and xaliproden on adult brain neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

A new mouse mutant with progressive motor neuronopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Drug‐induced defaecation in rats: role of central 5‐HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903329089

10.1517/13543780903329089

21 January 2018

Identifiers

DOI

1 reference

17 June 2017

1 reference